Juan Ramírez

Juan Ramírez

Auto-generated profile, based on publicly available information

Juan Ramírez

Ecopetrol (Colombia) , Instituto Colombiano del petróleo y energías de la Transición ICPET. Piedecuesta Santander Colombia

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2015 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
BIBraulio Insuasty
Braulio Insuasty
JRJuan Ramírez
Juan Ramírez
DBDiana Becerra
Diana Becerra
CECarlos Echeverry
Carlos Echeverry
JQJairo Quiroga
Jairo Quiroga
JCJusto Cobo
Justo Cobo

12 March 2019 in Energy & Fuels
Verified
Journal Article
Closed access
JRJuan S. Ramírez-Pradilla
Juan S. Ramírez-Pradilla
CBCristian Blanco-Tirado
Cristian Blanco-Tirado
MHMarie Hubert-Roux
Marie Hubert-Roux
PGPierre Giusti
Pierre Giusti
Carlos AfonsoCarlos Afonso
Carlos Afonso
MCMarianny Y. Combariza
Marianny Y. Combariza

1 August 2018 in Fuel
Verified
Journal Article
Closed access
DGDeisy Giraldo-Dávila
Deisy Giraldo-Dávila
MCMartha L. Chacón-Patiño
Martha L. Chacón-Patiño
JRJuan S. Ramirez-Pradilla
Juan S. Ramirez-Pradilla
CBCristian Blanco-Tirado
Cristian Blanco-Tirado
MCMarianny Y. Combariza
Marianny Y. Combariza

1 March 2015 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
JRJuan Ramírez
Juan Ramírez
LSLaura Svetaz
Laura Svetaz
JQJairo Quiroga
Jairo Quiroga
RARodrigo Abonia
Rodrigo Abonia
MRMarcela Raimondi
Marcela Raimondi
BIBraulio Insuasty
Braulio Insuasty

22 February 2019 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
JRJuan S. Ramírez-Pradilla
Juan S. Ramírez-Pradilla
CBCristian Blanco-Tirado
Cristian Blanco-Tirado
MCMarianny Y. Combariza
Marianny Y. Combariza

13 May 2013 in Molecules
Verified
Journal Article
Open access
PDF file
AIAlberto Insuasty
Alberto Insuasty
JRJuan Ramírez
Juan Ramírez
MRMarcela Raimondi
Marcela Raimondi
CECarlos Echeverry
Carlos Echeverry
JQJairo Quiroga
Jairo Quiroga
BIBraulio Insuasty
Braulio Insuasty
New hetaryl- and alkylidenerhodanine derivatives 3a–d, 3e, and 4a–d were prepared from heterocyclic aldehydes 1a–d or acetaldehyde 1e. The treatment of several rhodanine derivatives 3a–d and 3e with piperidine or morpholine in THF under reflux, afforded (Z)-5-(hetarylmethylidene)-2-(piperidin-1-yl)thiazol-4(5H)-ones and 2-morpholinothiazol-4(5H)-ones 5a–d, 6a–d, and (Z)-5-ethylidene-2-morpholinothiazol-4(5H)-one (5e), respectively, in good yields. Structures of all compounds were determined by IR, 1D and 2D NMR and mass spectrometry. Several of these compounds were screened by the U.S. National Cancer Institute (NCI) to assess their antitumor activity against 60 different human tumor cell lines. Compound 3c showed high activity against HOP-92 (Non-Small Cell Lung Cancer), which was the most sensitive cell line, with GI50 = 0.62 μM and LC50 > 100 μM from the in vitro assays. In vitro antifungal activity of these compounds was also determined against 10 fungal strains. Compound 3e showed activity against all fungal strains tested, but showed high activity against Saccharomyces cerevisiae (MIC 3.9 μg/mL).